The statements below are read from VILIN BIO MED LIMITED’s filed results, 6 filed quarters and 7 fiscal years on record, standalone basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: H2 FY25-26 · filed Jul 18, 2026 · audited
This company files half-yearly statements with the exchange — each column is a six-month period; discrete quarterly figures are not published.
| ₹ Cr | H1 FY24Sep 2023 | H2 FY24Mar 2024 | H1 FY25Sep 2024 | H2 FY25Mar 2025 | H1 FY26Sep 2025 | H2 FY26Mar 2026Latest | YoYlatest |
|---|---|---|---|---|---|---|---|
| Sales | 7.65 | 8.16 | 4.49 | 10.3 | 9.66 | 32.6 | +216.0% |
| 6.26 | 8.73 | 4.07 | 9.95 | 9.33 | 29.7 | +198.9% | |
| Operating profit | 1.39 | -0.57 | 0.42 | 0.37 | 0.34 | 2.86 | n/m |
| OPM % | 18.2% | -7.0% | 9.4% | 3.5% | 3.5% | 8.8% | +5.2 pp |
| Other income | 0.11 | 0.22 | 0.22 | 0.25 | 0.00 | 0.00 | -99.5% |
| Interest | 0.38 | 0.41 | 0.41 | 0.44 | 0.07 | 0.00 | -99.7% |
| Depreciation | 0.08 | 0.05 | 0.07 | 0.03 | 0.07 | 0.21 | n/m |
| Profit before tax | 1.04 | -0.82 | 0.15 | 0.15 | 0.19 | 2.65 | n/m |
| Tax % | 26.3% | n/a (loss) | 19.1% | 34.8% | 21.7% | 32.9% | -1.9 pp |
| Net profit | 0.77 | -0.82 | 0.12 | 0.10 | 0.15 | 1.78 | n/m |
| EPS (₹) | 0.55 | 0.00 | 0.00 | 0.07 | 0.11 | 1.26 | n/m |
No results filing with a recorded time yet — reactions appear from the first quarter whose announcement we timestamped (May 2026 onward), on the session the market could trade it.
